Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CCELthis companyCryo-Cell International, Inc.	$5.07	-13.27×	-1.73×	1.02×	39.51×	-331.7%	76.6%	15.3%	-7.7%	13.1%	10.8%	16.3%	-0.62×	10.24×	2.34×	0.59×	10.1%	6	-0.05	1	C-
JSPRJasper Therapeutics, Inc.	$15.23	-0.46×	8.45×	0×	-0.1×	128.1%	0.0%	0.0%	0.0%	-1826.1%	-338.1%	-220.0%	0.3×	0.37×	0×	2.62×	0.0%	0	-45.56	2	C+
LIMNLiminatus Pharma, Inc. Class A Common Stock	$2.75	-1.42×	-1.48×	0×	-1.56×	-235.7%	0.0%	0.0%	0.0%	104.0%	35.6%	-68.9%	-0.15×	-0.11×	-13.75×	0.05×	0.0%	2	-28.31	1	D+
NMTCNeuroOne Medical Technologies Corporation	$0.92	-9.87×	5.04×	2.95×	-9.76×	-18014.5%	67.3%	-34.9%	-29.8%	-51.0%	-49.1%	-8.2%	0.04×	2.09×	-12.65×	4.44×	0.0%	3	-18.47	1	C-
PIIIP3 Health Partners Inc.	$4.02	-0.08×	-0.07×	0.01×	-1.49×	-13900.3%	-9.9%	-18.5%	-10.1%	95.3%	-172.8%	-799.7%	-1.84×	-1.43×	-4.91×	0.24×	0.0%	3	-0.29	2	C
RMTIRockwell Medical, Inc.	$7.68	-5.56×	0.81×	0.43×	-15.9×	-661.9%	16.9%	-6.8%	-7.7%	-14.4%	-9.5%	-4.0%	0.34×	-0.88×	-4.17×	3.98×	0.0%	5	-7.74	2	C
Peer median	—	-1.42×	0.81×	0.01×	-1.56×	-661.9%	0.0%	-6.8%	-7.7%	-14.4%	-49.1%	-68.9%	0.04×	-0.11×	-4.91×	2.62×	0.0%	3	-18.47	2	—